Actively hiring
Drug Discovery
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
501-1000
employees, estimated range
Backers
2
Canaan, SR One
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2024
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Draupnir Bio is developing new innovative therapies for patients.

We navigate evolutionary data to translate extreme biological adaptations into first-in-class medicines. Learn more about our process.

Xylo is pioneering next-generation therapeutics designed to rewire neural circuits and restore brain function. Discover our innovative…

Precision biomarkers that quantify functional brain change. Supporting drug development and brain health programs.

Novogaia is an applied AI drug discovery company that builds machine learning systems to decode the chemistry of natural organisms…

Our goal is to streamline drug development in order to accelerate patient access to important medical therapies.

Canaan
SR One 




